Dr Reddy's Signs Commercialisation Deal With Hatchtech

New Delhi: Drugmaker Dr Reddy's Laboratories said it has signed a commercialisation deal with Australia's Hatchtech for the latter's prescription head lice product Xeglyze Lotion. As part of the agreement, Dr Reddy's will pay Hatchtech an upfront $10 million, followed by up to $50 million based on pre-commercialisation milestones and an undisclosed amount based on post-commercialisation milestones, linked to achievement of annual ne...